Tom Clarke (Director, NHS Insight & Interaction) explores what new integrated care legislation means for UK market access and for industry engagement with NHS decision-makers across England. July 1st saw...
Read More
On 1st July we saw the introduction of legislation for Integrated Care Systems (ICSs) in the NHS. In the weeks since, what has changed for healthcare leaders, practitioners and patients?...
Read More
Emma Frood recently joined Mtech Access as an Associate Consultant in our market access team. In this interview, she tells us about her experiences and activities in her first few...
Read More
How will the legislation of Integrated Care Systems in July 2022, and the ‘New NHS’ impact on Pharma market access? NHS England is going through its most significant changes for...
Read More
People, pathways, and payments – Mastering the key pillars of NHS engagement in 2023 Pharma and Medtech market access professionals joined us and our guest speakers from across the NHS...
Read More
What roles and responsibilities do Clinical Pharmacists have in the NHS? How can Pharma and Medtech engage Clinical Pharmacists, and how can industry best support these new decision-makers? In this...
Read More
Specialised services have long been the subject of debate around their place in Integrated Care Systems (ICSs), who will run them and how will they be funded. On 31st May...
Read More
As the NHS takes steps towards a more integrated future, how are systems and care pathways transforming? How is change being implemented, and what does this look like in reality...
Read More
On 13th April NHS England published the initial 2022/23 budgets of the 42 Integrated Care Boards (ICBs) expected to go live from 1st July 2022, subject to legislative approval. The...
Read More
NHS England published its 2022/23 National Tariff Payment System on 31st March 2022, a day before the new NHS financial year. The system provides guidance for the continued running of...
Read More
